Huizing E H, Mechelse K, Staal A
Acta Otolaryngol. 1981 Jul-Aug;92(1-2):115-21. doi: 10.3109/00016488109133245.
In this paper the basic requirements for a clinical therapeutic trial in Bell's palsy are discussed. The available therapeutic studies are analysed in view of these requirements. The following conclusions seem justified: (1) Galvanic stimulation has not been proved to lead to a better recovery. (2) There is no evidence that decompression of the mastoid part of the facial nerve in the second or third week has a positive effect. Whether surgery at an earlier stage or decompression of the complete intratemporal part of the nerve is effective, has not yet been studied. (3) There is no convincing proof that prednisone administration up to a daily dose of 60-80 mg during the first days has any effect.
本文讨论了贝尔面瘫临床治疗试验的基本要求。根据这些要求对现有的治疗研究进行了分析。以下结论似乎是合理的：（1）电刺激尚未被证明能带来更好的恢复。（2）没有证据表明在第二或第三周对面神经乳突部进行减压有积极效果。神经早期手术或颞骨内全程减压是否有效，尚未进行研究。（3）没有令人信服的证据表明在最初几天每天服用高达60 - 80毫克的泼尼松有任何效果。
